Protein Labeling Services: Core Technology System from Solid-Phase Conjugation to Bifunctional Crosslinking

This article systematically elaborates on two major technical approaches—solid-phase protein labeling and biomacromolecule-protein labeling—focusing on the principles and methodologies of protein labeling services. It analyzes the classification characteristics and selection strategies of crosslinkers, and details the protein-protein crosslinking processes mediated by dual crosslinkers SPDP and SMCC, along with key operational points.

  • Recent Advances
  • Product Information
Recent Advances
Protein Labeling Services: From Solid-Phase Conjugation to Bifunctional Crosslinking Core Technology Systems
Overview
This article systematically elaborates on the technical principles and methodological systems of protein labeling services, covering two major technical pathways: solid-phase-protein labeling and biomolecule-protein labeling. It analyzes the classification characteristics and selection strategies of crosslinkers, detailing the SPDP and SMCC bifunctional reagent-mediated protein-protein crosslinking process and key operational points.
I. Technical Classification and Application Background of Protein Labeling Services
Labeling techniques are commonly used in immunoassays and can be broadly divided into two categories: solid-phase-protein labeling and biomolecule-protein labeling. Common solid-phase materials include NC membranes, PVDF membranes, latex microspheres, magnetic microspheres, time-resolved microspheres, quantum dots, etc. NC and PVDF membranes are mainly used in immunoblotting-related products or nucleic acid hybridization, relying on physical adsorption through hydrophobic interactions and electrostatic forces. Microspheres are typically produced via styrene polymerization to obtain polystyrene polymers of different sizes or structures. Polystyrene can be directly used for protein coating (e.g., ELISA plates) or modified with functional groups (e.g., —NH₂, —COOH, —CHO, —SH) to covalently react with proteins. Other microspheres like quantum dots use materials such as cadmium sulfide for modification and protein conjugation.

Common labeling includes biotin or fluorescent labeling of antibodies, antigens, or other proteins, or conjugating proteins to microspheres. Most enzymes, antigens, or antibodies fall under the protein category, so enzyme-labeled antibodies essentially involve protein-protein conjugation. The labeling principle typically exploits the nucleophilic properties of protein α-amino, ε-amino, imino, and sulfhydryl groups. For microsphere-protein labeling, the main approach involves modifying microspheres with functional groups (e.g., —NH₂, —COOH, —CHO, —SH) and activating these groups using agents like EDC, NHS/EDC, or DTT, followed by crosslinking with corresponding protein groups.

II. Classification Characteristics and Selection Strategies of Crosslinkers
Many factors affect protein conjugation efficiency, but the primary determinants are the types and quantities of functional groups carried by the proteins. Different crosslinkers can be selected based on these functional groups. Crosslinkers can be monofunctional, bifunctional, or multifunctional. Bifunctional crosslinkers are further divided into homotypic (same functional groups) and heterotypic (different functional groups).
Homotypic bifunctional crosslinkers like N-hydroxysuccinimide esters are specific to amino groups, while glutaraldehyde can react with amino groups to form Schiff bases and with hydroxyl groups via aldol condensation. Heterotypic bifunctional crosslinkers like SPDP react with amino groups on one end and sulfhydryl groups on the other, offering high reactivity but lacking specificity. Enzyme-labeled antibodies are typically conjugated using glutaraldehyde or sodium periodate methods, but these can produce enzyme-enzyme or antibody-antibody aggregates. To mitigate this, SPDP can be used to reduce self-polymerization.
III. Principles of Bifunctional Crosslinker-Mediated Protein-Protein Conjugation
If the functional groups of a protein are known, using the above crosslinkers is straightforward. For unknown proteins, directly applying these methods may be challenging. In such cases, two crosslinkers can be employed, as illustrated by the SPDP and SMCC example.
SPDP contains succinimide and thiol groups. The succinimide group reacts with amino groups (e.g., lysine residues) on Protein A, introducing thiol groups. SMCC contains succinimide and maleimide groups, conjugating to Protein B via succinimide to introduce maleimide groups. A reducing agent like DTT or TCEP is used to reduce Protein A, generating free thiols that rapidly react with Protein B's maleimide groups to form stable thioether bonds. Residual thiols are blocked with thiol-containing agents like NEM to prevent self-polymerization via disulfide bonds. Further purification may be optional depending on application needs.
IV. Standardized Operational Procedures for Protein Labeling Services
Based on the above principles, protein processing involves the following steps. For protein thiolation: transfer Protein A to a centrifuge tube; dialyze or desalt with PBS if buffer components may affect reaction efficiency; dissolve SPDP in DMSO and add to Protein A at the calculated molar ratio; mix thoroughly and react at room temperature for 1–2 hours; remove excess SPDP. For protein maleimidation: similarly prepare Protein B with SMCC.
For Protein A reduction: prepare TCEP (1 mg/mL) and add to Protein A at a 10:1 molar ratio (TCEP:Protein A), reacting for 15 minutes at room temperature. For conjugation: mix reduced Protein A and maleimidated Protein B at a 1:1 molar ratio, reacting for 3 hours at room temperature or overnight at 2–8°C. For blocking: add NEM (1 mg/mL) to quench residual thiols, incubating for 30 minutes. Purification may be omitted unless protein amounts exceed 2 mg. For storage, add stabilizers (e.g., BSA, sugars) or preservatives if concentration is below 1 mg/mL.
V. Key Operational Considerations for Protein Labeling Services

Critical notes: (1) TCEP is corrosive—avoid contact; use 10:1 TCEP:Protein A molar ratio. (2) DTT reduces disulfide bonds at 10–50 mM (typically 25 mM); 1–10 mM maintains free thiols. (3) NEM is toxic and corrosive—handle with care; dissolve slowly (5–10 minutes). (4) SPDP hydrolyzes easily—prepare fresh in DMSO; recommended SPDP:Protein A molar ratio is 20:1. (5) SMCC has poor solubility—consider sulfo-SMCC; maleimide groups degrade at pH >8; use within 3 hours; recommended SMCC:Protein B ratio is 20:1. (6) Conjugation efficiency depends on protein quantity—initial trials should use ≥100 µg or inexpensive proteins (e.g., BSA) with electrophoresis validation. (7) Use PBS (0.1 M, pH 7.5–8.0) for dissolution.

VI. Conclusion
In practical applications, biotinylation is one of the most widely used protein labeling techniques. For Avitag fusion protein biotinylation, Uni-Offer provides Biotin Labeling for Avitag Protein services. This service utilizes biotin ligase to specifically recognize lysine sites in Avitag sequences, enabling site-specific monobiotinylation and avoiding heterogeneity from chemical labeling. Labeled proteins can be used for streptavidin-based detection, protein interaction studies, and diagnostic reagent development.
Protein labeling services, as core technologies for immunoassays and protein research, encompass solid-phase-protein and biomolecule-protein labeling pathways. From crosslinker selection to bifunctional reagent mechanisms, standardized protocols to critical precautions, the protein labeling system has established a robust methodological framework. The Biotin Labeling for Avitag Protein service provides a reliable, site-specific solution for Avitag fusion protein biotinylation, driving advancements in immunoassays and protein research.

```

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Target proteins | membrane proteins | cytokines | enzymes | viral antigens | protein customization
Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience
Nanjing UA Biotechnology Co., Ltd. Email:order@ua-bio.com Phone:+86-25-56221161
公众号
Product Information
The Last The Next